With apologies to the Sunday morning talk show commentators, any explanation for the November 2 election results other than Covid-19 must be labelled incidental…
Read More about Covid-19 Just Voted And It Will Vote Again In 2022
Last night’s US Food and Drug Administration (FDA) announcement approving Moderna and Johnson & Johnson’s Covid-19 boosters, and the simultaneous endorsement of the mixing of vaccines with boosters from all three approved manufacturers, sets the stage for today’s meeting of the CDC Advisory Committee on Immunization Practices (ACIP).
Read More about What Today’s CDC Covid-19 Vaccine Panel Needs To Confront
Steve Brozak, DMH, Managing Partner and President of WBB Securities moderated a panel titled “Manufacturing: The Next Big COVID Problem or Worse?” at the BioFuture conference on Wednesday, October 6, 2021.
Read More about “Manufacturing: The Next Big COVID Problem or Worse?”Steve Brozak, DMH, Managing Partner and President of WBB Securities will moderate a panel at BioFuture on October 6, 2021.
Read More about WBB Securities President Steve Brozak will Moderate a panel at the BioFuture Conference on Wednesday, October 6, 2021
Friday’s FDA Vaccines and Related Biological Products (VRBPAC) meeting on Pfizer’s Covid-19 vaccine booster…
Read More about FDA And Pfizer Need A Covid-19 Reality Booster
In the last 24-hours vaccine makers, Moderna and Novavax both released positive….
Read More about Novavax’s Manufacturing Issues Are Solvable, But Covid-19 Vaccine Herd Immunity May Not Be